Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to β-lactamase

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 1, 1997, Pages 31-34

  Matsumura, Naoki ^a   Minami, Shinzaburo ^b   Mitsuhashi, Susumu ^b  

^a Episome Institute   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORINASE; IMIPENEM; PENEM 2 CARBOXYLIC ACID DERIVATIVE; PENICILLINASE; T 5575; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG STABILITY; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CEFTAZIDIME; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; HYDROLYSIS; IMIPENEM; KINETICS; MUTATION;

EID: 0031059065     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.1.31     Document Type: Article

References (14)

1. Sanders, C. C. & Sanders, W. E. (1985). Microbial resistance to newer generation /Mactam antibiotics: clinical and laboratory implications. Journal of Infectious Diseases 151, 399-406.
2. Livermore, D. M. (1987). Clinical significance of beta-lactamase induction and stable derepression in Gram-negative rods. European Journal of Clinical Microbiology 6, 439-45.
3. Sanders, C. C. (1987). Chromosomal cephalosporinases responsible for multiple resistance to newer β-lactam antibiotics. Annual Review of Microbiology 41, 573-93.
4. Watanabe, Y., Minami, S., Hayashi, T., Araki, H., Kitayama, R. & Ocniai, H. (1995). In vitro antibacterial properties of T-5575 and T-5578, novel parenteral 2-carboxypenams. Antimicrobial Agents and Chemotherapy 39, 2787-91.
5. Matsumura, N. & Mitsuhashi, S. (1995). A β-lactamase from Serratia marcescens hydrolyzing the 2-carboxypenam T-5575. Antimicrobial Agents and Chemotherapy 39, 2132-4.
6. Mitsuhashi, S. & Inoue, M. (1981). Mechanisms of resistance to β-lactam antibiotics. In Beta-lactam Antibiotics (Mitsuhashi, S., Ed.), pp. 41-56. Japan Scientific Societies Press, Tokyo.
7. Saino, Y., Kobayashi, F., Inoue, M. & Mitsuhashi, S. (1982). Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrobial Agents and Chemotherapy 22, 564-70.
8. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 35, 147-51.
9. Waley, S. G. (1974). A spectrophotometric assay of β-lactamase action on penicillins. Biochemical Journanl 139, 789-90.
10. Minami, S., Araki, H., Yasuda, T., Akama, M., Iyobe, S. & Mitsuhashi, S. (1993). High-level imipenem resistance associated with imipenem-hydrolyzing beta-lactamase production and outer membrane alteration in a clinical isolate of Pseudmonas aeruginosa. International Journal of Experimental and Clinical Chemotherapy 6, 21-8.
11. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H. et al. (1994). Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 38, 71-8.
12. Iyobe, S., Tsunoda, M. & Mitsuhashi, S. (1994). Cloning and expression in Enterobacteriaceae of the extended-spectrum β- lactamase gene from a Pseudomonas aeruginosa plasmid. FEMS Microbiology Letters 121, 175-80.
13. Minami, S., Akama, M., Araki, H., Watanabe, Y., Narita, H., Iyobe, S. et al. (1996). Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B β- lactamase. Journal of Antimicrobial Chemotherapy 37, 433-44.
14. Inoue, E. & Mitsuhashi, S. (1994). In vitro antibacterial activity and β-lactamase stability of SY5555, a new oral penem antibiotic. Antimicrobial Agents and Chemotherapy 38, 1974-9.